C96.2 - Malignant mast cell neoplasm
- Applicable to Malignant mast cell neoplasm
- The 2025 edition of ICD10-CM C96.2 became effective on October 1, 2024.
- This is the American ICD10-CM version of C96.2 - other international versions of ICD10 C96.2 may differ.
- C96.2 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C96.2 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C96.2 - Malignant mast cell neoplasm
- C96.2 - Malignant mast cell neoplasm
- C96.20 - Malignant mast cell neoplasm, unspecified
- C96.21 - Aggressive systemic mastocytosis
- C96.22 - Mast cell sarcoma
- C96.29 - Other malignant mast cell neoplasm
Type 1 Excludes
- indolent mastocytosis (D47.02)
- mast cell leukemia (C94.30)
- mastocytosis (congenital) (cutaneous) (Q82.2)
Non-Billable/Non-Specific Code
The following codes above C96.2 contain annotation back-references that may be applicable to C96.2:
- Chapter: C00-D49 - Neoplasms
- Section: C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category: C96 - Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com